ARNA - Arena Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 1.50
52-Week Change 323.45%
S&P500 52-Week Change 324.46%
52 Week High 364.48
52 Week Low 335.04
50-Day Moving Average 347.58
200-Day Moving Average 352.95

Share Statistics

Avg Vol (3 month) 3373.1k
Avg Vol (10 day) 3389.83k
Shares Outstanding 550.11M
Float 50.02M
% Held by Insiders 10.16%
% Held by Institutions 185.23%
Shares Short (Nov 29, 2019) 43M
Short Ratio (Nov 29, 2019) 48.61
Short % of Float (Nov 29, 2019) 46.05%
Short % of Shares Outstanding (Nov 29, 2019) 45.98%
Shares Short (prior month Oct 31, 2019) 42.8M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Jun 19, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin 68.29%
Operating Margin (ttm)67.30%

Management Effectiveness

Return on Assets (ttm)36.89%
Return on Equity (ttm)66.12%

Income Statement

Revenue (ttm)812.08M
Revenue Per Share (ttm)16.37
Quarterly Revenue Growth (yoy)-62.20%
Gross Profit (ttm)-97.06M
EBITDA 549.79M
Net Income Avi to Common (ttm)554.58M
Diluted EPS (ttm)10.84
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)783.76M
Total Cash Per Share (mrq)15.64
Total Debt (mrq)63.09M
Total Debt/Equity (mrq)5.51
Current Ratio (mrq)21.90
Book Value Per Share (mrq)22.93

Cash Flow Statement

Operating Cash Flow (ttm)596.44M
Levered Free Cash Flow (ttm)386.15M